Increased PDE5 expression has also been reported in various cell lines deriving from breast cancer (MCF-7, HTB-26, MDA-MB-468) [54], giving the rational to assess the anticancer effects of PDE5 inhibition. Here, PDE5A is linked to breast cancer.